Avalo Therapeutics, Inc.
$927.80M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15725.35x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17479.74x
$19.23Latest market snapshot
Implied fair value · at LOPE's multiple
$0.00100.0% below market
0.00 AVTX revenue / share×3.60x LOPE P/S=$0.00
Market $19.23Implied $0.00
LOPE · current priceP/S 3.60x
$152.70Latest market snapshot
Implied fair value · at AVTX's multiple
$741,752.89485,658.3% above market
42.44 LOPE revenue / share×17479.74x AVTX P/S=$741,752.89
Market $152.70Implied $741,752.89